1. Home
  2. TTC vs AXSM Comparison

TTC vs AXSM Comparison

Compare TTC & AXSM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Toro Company (The)

TTC

Toro Company (The)

HOLD

Current Price

$94.15

Market Cap

9.3B

ML Signal

HOLD

Logo Axsome Therapeutics Inc.

AXSM

Axsome Therapeutics Inc.

HOLD

Current Price

$164.87

Market Cap

9.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
TTC
AXSM
Founded
1914
2012
Country
United States
United States
Employees
N/A
N/A
Industry
Tools/Hardware
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
9.3B
9.0B
IPO Year
1994
2015

Fundamental Metrics

Financial Performance
Metric
TTC
AXSM
Price
$94.15
$164.87
Analyst Decision
Buy
Strong Buy
Analyst Count
4
17
Target Price
$104.00
$210.65
AVG Volume (30 Days)
976.5K
481.9K
Earning Date
03-05-2026
05-04-2026
Dividend Yield
1.66%
N/A
EPS Growth
N/A
38.56
EPS
0.69
N/A
Revenue
$2,618,650,000.00
N/A
Revenue This Year
$6.11
$58.18
Revenue Next Year
$4.45
$55.45
P/E Ratio
$136.06
N/A
Revenue Growth
4.53
N/A
52 Week Low
$62.34
$86.99
52 Week High
$105.19
$191.50

Technical Indicators

Market Signals
Indicator
TTC
AXSM
Relative Strength Index (RSI) 42.83 50.39
Support Level $76.60 $153.37
Resistance Level $102.32 $169.11
Average True Range (ATR) 2.41 4.25
MACD -0.47 0.92
Stochastic Oscillator 22.78 72.17

Price Performance

Historical Comparison
TTC
AXSM

About TTC Toro Company (The)

The Toro Co designs, manufactures, markets, and sells professional turf maintenance equipment and services; turf and agricultural irrigation systems; landscaping equipment and lighting products; snow and ice management equipment; construction equipment; and residential yard and snow thrower products. The company operates through Professional and Residential segments, with the Professional segment serving commercial, agricultural, and construction customers and generating the majority of revenue, while the Residential segment focuses on homeowners. Its products are sold through distributors, dealers, retailers, rental centers, and direct channels, with the United States as its primary revenue-generating market.

About AXSM Axsome Therapeutics Inc.

Axsome Therapeutics Inc is a clinical-stage biopharmaceutical company. It is engaged in developing novel therapies for the management of the central nervous system, or CNS, disorders for which there are limited treatment options. Its pipeline products includes AXS-05, AXS-07, AXS-12, and AXS-14. It manages its business as one operating segment and reporting unit, which is the business of developing and delivering novel therapies for the management of CNS disorders.

Share on Social Networks: